FDA Approved: RECORLEV — Original Application (Xeris Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Recorlev (levoketoconazole) by Xeris Pharmaceuticals as an original approval for the treatment of adults with endogenous Cushing's syndrome. This m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• RECORLEV (Levoketoconazole)

Snippet

ORIG AP for RECORLEV (LEVOKETOCONAZOLE)